Veterinary Vaccines Market Size, Share, Growth, Analysis, Trend, and Forecast Research Report by 2027

Comments · 578 Views

The Global Veterinary Vaccines Market Report, published by Emergen Research, offers an industry-wide assessment of the Veterinary Vaccines market, which is inclusive of the most crucial factors contributing to the growth of the industry.

The Global Veterinary Vaccines Market Report, published by Emergen Research, offers an industry-wide assessment of the Veterinary Vaccines market, which is inclusive of the most crucial factors contributing to the growth of the industry. The latest research report comprises an extensive analysis of the micro- and macro-economic indicators that influence the global market development during the forecast period of 2020-2027. The current trends of the Veterinary Vaccines market, combined with a wide array of growth opportunities, key drivers, restraints, challenges, and other critical aspects, have been vividly detailed in the Veterinary Vaccines market report. Furthermore, the report takes into account various market dynamics, which, in turn, generate a plethora of developmental prospects for the leading players involved in the of the Veterinary Vaccines industry.

Factors influencing the growth of the Veterinary Vaccines market and impacting the growth of the industry are studied extensively in the report. The report considers the COVID-19 pandemic as one of the key influencing factors of the Veterinary Vaccines market. The report discusses in detail the positive and negative impact of the pandemic on the Veterinary Vaccines industry. The supply chain disruptions and economic volatility have altered the dynamics of the Veterinary Vaccines industry. The report explores the effects of the pandemic on the market and its key segments and regions. It also offers a forecast estimation of the market growth in a post-COVID-19 scenario. 

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/veterinary-vaccines-market

 

Market Overview:

The research report on the Veterinary Vaccines market is formulated through extensive primary and secondary research along with qualitative and quantitative analysis of vital aspects of the market. The insightful data is further validated and verified by the industry professionals. The report strives to offer deeper insights into the overall market scenario of the Veterinary Vaccines business sphere.

Key Highlights of Report

  • In January 2020, Automazioni VX, Inc. entered into a cooperative agreement with Merck Animal Health, a division of Merck KGaA. The collaboration was aimed to launch Innoject Pro, a uniquely developed technology for subcutaneous injection vaccination of chicken. The technology can be utilized in conjunction with the Innovax vaccine by Merck Animal Health, which is used to safeguard poultry from bacterial infections.
  • The poultry segment is expected to lead the global veterinary vaccines market throughout the forecast period, expanding at a CAGR of 7.0%. The increased need for risk-free pet food, associated with a growing focus on developing new animal protection approaches, is estimated to drive the segment during the forecast period.
  • The injection segment is projected to retain the largest market share throughout the forecast period. Growth of the segment is attributable to increasing use of injection vaccines for protection of animal health. Injection vaccines play a crucial role in preventing and controlling the dissemination of disease outbreaks in both farm animals and livestock.

Some major companies operating in the global market include Kerry Group, BASF SE, Cargill Inc., Evonik Industries AG, Clariant AG, AkzoNobel NV, Ingredion Inc., Solvay SA, Archer Daniels Midland Company, and Royal DSM.

Emergen Research has segmented the global veterinary vaccines market based on type, administration path, technology, infection, and region.

  • Type Outlook (Revenue, USD Billion; 2017–2027)
    • Poultry
    • Swine
    • Aquaculture
    • Cattle
    • Cat
    • Dog
  • Administration Path Outlook (Revenue, USD Billion; 2017–2027)
    • Oral
    • Injection
    • Spray/Immersion
  • Technology Outlook (Revenue, USD Billion; 2017–2027)
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Toxoid
  • Infection Outlook (Revenue, USD Billion; 2017–2027)
    • Fungal
    • Bacterial
    • Parasitic
    • Viral
  • Regional Outlook (Revenue, USD Billion; 2017–2027)
    • North America
      1. S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

 

 

 

 

 

Comments